Skip to content

Therapeutic Exercise and Education in Neurophysiology of Pain in the Quality of Life of Women With Endometriosis

Therapeutic Exercise and Education in Neurophysiology of Pain in the Quality of Life of Women With Endometriosis: Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05679063
Enrollment
40
Registered
2023-01-10
Start date
2022-12-29
Completion date
2025-05-01
Last updated
2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

The objective of this study will be to evaluate treatment using ET exercise and pain education in women with endometriosis to achieve improvement in quality of life.

Detailed description

A study will be carried out whose objective is to improve the quality of life in women with endometriosis through a program of therapeutic exercise and education in the neurophysiology of pain. Also as secondary variables will be observed: menstrual symptoms, sexual function, and abdominal wall thickness measured with ultrasound.

Interventions

OTHERPhysiotherapy

A program of therapeutic exercise and education in the neurophysiology of pain will be applied to the participants of the experimental group

OTHERSham, Control

Talks about healthy habits

Sponsors

University of Valladolid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The participants will not know in which treatment group they are, and the investigator in charge of carrying out the evaluation will not know to which group the subjects he evaluates belong to.

Intervention model description

Trough a randomization program, participants will be assigned to the treatment group or the control group.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Women of reproductive age between 18 and 45 years. * Women with a medical diagnosis of endometriosis. * Women with visual analog scale (EVA) between 4 and 10 (moderate-severe pain) during the last 3 months in the suprapubic area, abdomen or perineum both continuously and intermittently.

Exclusion criteria

* Women who must have surgery during the study. * Women who have undergone abdominal or pelvic surgery or who have given birth (vaginal or cesarean) in the last 6 months. * Women who are pregnant or planning a pregnancy. * Women with uncorrected pacemakers or coagulopathies, severe comorbid disorder, cancer (in the last 5 years or at present), severe mental disorders, or neuropathies affecting the nerves of the pelvis or lower extremities. * Physiotherapy treatments or treatments related to pathology or study areas 15 days prior to the beginning of the study. * Variations in medication in the 3 months prior to the start of the stud

Design outcomes

Primary

MeasureTime frameDescription
Changes in quality of life perception assessed using EUROQuOL 5D - 5LBaseline, Up to 1 month, Up to 3 months.The scale will be administered by one of the researchers, This scale covers five dimensions, each of which is assigned a score from 1 to 5, and with these scores, a code is obtained that indicates the person's quality of life. High values indicate poor quality of life.

Secondary

MeasureTime frameDescription
Abdominal wall muscle thicknessBaseline, Up to 1 month, Up to 3 monthsThe muscle thickness of the abdominal wall with ultrasound according to a defined protocol.
Sexual Function assessed usinf Female Sexual Function Index (IFSF)Baseline, Up to 1 month, Up to 3 monthsThe scale will be administered by one of the researchers. This questionnaire consists of 19 questions and is grouped into six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain; each question has 5 or 6 options, assigning them a score ranging from 0 to 5. The score for each domain is multiplied by a factor and the result final is the arithmetic sum of the domains. A higher score better sexuality
Symptoms associated with menstruation assessed using CVM-22 (quality of life related to menstruation)Baseline, up to 1 month, up to 3 monthsThe scale will be administered by one of the researchers. Minimin value = 0. Maximum value = 66. A high result indicates a good quality of life-related to menstruation

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026